Rhumbline Advisers Has $74.13 Million Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Rhumbline Advisers lifted its position in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 5.6% in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 62,774 shares of the medical instruments supplier's stock after acquiring an additional 3,338 shares during the quarter. Rhumbline Advisers owned approximately 0.30% of Mettler-Toledo International worth $74,130,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. lifted its holdings in shares of Mettler-Toledo International by 14.7% in the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier's stock valued at $332,634,000 after purchasing an additional 28,478 shares in the last quarter. Blue Trust Inc. raised its position in Mettler-Toledo International by 70.8% during the fourth quarter. Blue Trust Inc. now owns 41 shares of the medical instruments supplier's stock valued at $50,000 after buying an additional 17 shares during the period. Caprock Group LLC lifted its stake in Mettler-Toledo International by 11.4% in the 4th quarter. Caprock Group LLC now owns 487 shares of the medical instruments supplier's stock worth $596,000 after acquiring an additional 50 shares in the last quarter. Conestoga Capital Advisors LLC boosted its position in Mettler-Toledo International by 9.9% during the 4th quarter. Conestoga Capital Advisors LLC now owns 343 shares of the medical instruments supplier's stock worth $420,000 after acquiring an additional 31 shares during the period. Finally, Optas LLC acquired a new stake in Mettler-Toledo International during the 4th quarter worth about $225,000. Institutional investors and hedge funds own 95.07% of the company's stock.

Analyst Ratings Changes

MTD has been the subject of a number of research analyst reports. Wells Fargo & Company increased their price target on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a research report on Monday, May 5th. UBS Group upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and cut their target price for the stock from $1,530.00 to $1,350.00 in a research report on Tuesday, May 20th. Robert W. Baird decreased their target price on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating for the company in a research note on Tuesday, April 22nd. Citigroup raised shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price target on the stock in a research note on Monday, April 7th. Finally, Evercore ISI boosted their target price on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an "outperform" rating in a research note on Monday, February 10th. Seven analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $1,302.11.

Insider Transactions at Mettler-Toledo International

In related news, Director Michael A. Kelly sold 1,062 shares of the firm's stock in a transaction on Wednesday, May 28th. The shares were sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the transaction, the director now directly owns 120 shares in the company, valued at approximately $139,191.60. This trade represents a 89.85% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 1.94% of the stock is owned by corporate insiders.

Mettler-Toledo International Price Performance

NYSE:MTD traded down $6.22 during trading hours on Thursday, reaching $1,163.45. The company's stock had a trading volume of 179,252 shares, compared to its average volume of 151,382. The company has a market cap of $24.18 billion, a price-to-earnings ratio of 28.71, a price-to-earnings-growth ratio of 3.30 and a beta of 1.40. Mettler-Toledo International Inc. has a one year low of $946.69 and a one year high of $1,546.93. The business's 50-day moving average is $1,092.15 and its 200-day moving average is $1,204.74.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.90 by $0.29. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. The company had revenue of $883.74 million during the quarter, compared to the consensus estimate of $876.61 million. During the same quarter in the prior year, the company posted $8.89 EPS. The firm's revenue was down 4.6% on a year-over-year basis. On average, sell-side analysts predict that Mettler-Toledo International Inc. will post 42.71 EPS for the current fiscal year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.